Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Print view.
German.
Contact.
Data entry.
Start.
Open Access.

Navigation/Search

Researchers.
Institutions.
Projects.
Publications.
Partners.
Sponsors.
Equipment.
Knowhow.
Fields of Research.

Selected Publication:

Harter, P; Wimberger, P; Okamoto, A; Reuss, A; Lim, MC; Rubio-Pérez, MJ; Vardar, MA; Scambia, G; Trédan, O; Hietanen, S; Colombo, N; Chudecka-Glaz, A; Petru, E; Lheureux, S; Van Nieuwenhuysen, E; Sehouli, J; Wenham, R; Ushijima, K; Indiviglio, S; Aghajanian, C.
Durvalumab plus paclitaxel/carboplatin plus bevacizumab followed by durvalumab, bevacizumab plus olaparib maintenance among patients with newly-diagnosed advanced ovarian cancer without a tumor BRCA1/BRCA2 mutation: Updated results from DUO-O/ENGOT-OV46/GOG-3025 Trial
GYNECOL ONCOL. 2024; 190: S65-S66. Doi: 10.1016/j.ygyno.2024.07.096 [Poster]
Web of Science FullText FullText_MUG

Authors Med Uni Graz:: Petru Edgar
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):